UK markets closed
  • FTSE 100

    7,009.71
    +25.12 (+0.36%)
     
  • FTSE 250

    17,292.14
    -11.97 (-0.07%)
     
  • AIM

    813.64
    -7.71 (-0.94%)
     
  • GBP/EUR

    1.1152
    -0.0024 (-0.21%)
     
  • GBP/USD

    1.0755
    +0.0024 (+0.23%)
     
  • BTC-GBP

    18,018.60
    -786.25 (-4.18%)
     
  • CMC Crypto 200

    442.40
    +13.61 (+3.18%)
     
  • S&P 500

    3,686.12
    +38.83 (+1.06%)
     
  • DOW

    29,427.08
    +292.09 (+1.00%)
     
  • CRUDE OIL

    80.78
    +2.28 (+2.90%)
     
  • GOLD FUTURES

    1,663.90
    +27.70 (+1.69%)
     
  • NIKKEI 225

    26,173.98
    -397.89 (-1.50%)
     
  • HANG SENG

    17,250.88
    -609.43 (-3.41%)
     
  • DAX

    12,185.13
    +45.45 (+0.37%)
     
  • CAC 40

    5,770.20
    +16.38 (+0.28%)
     

Global Bleeding Disorders Treatment Market Report 2022: Increased Focus of Pharmaceutical Companies on Recombinant Products Creates Opportunities

·3-min read
Company Logo
Company Logo

Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Bleeding Disorders Treatment Market By Drug Type, By Disease Type, By Distribution Channel, By End User By Region, Competition, Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.

The global bleeding disorders treatment market is projected to witness a steady CAGR during the forecast period, 2023-2027.

Factors such as the rise in the patient population base, increased healthcare expenditure by the public and private players, and growing disposable income for middle-class families drive the global bleeding disorders treatment market.

The ongoing research and development activities and the increased focus of pharmaceutical companies on recombinant products are expected to create lucrative growth opportunities for the global bleeding disorders treatment market in the next five years.

However, limited reimbursement and the high cost of availing of bleeding disorder treatment facilities may hinder the market growth in the forecast period.

Years considered for this report:

  • Historical Years: 2017 - 2020

  • Base Year: 2021

  • Estimated Year: 2022

  • Forecast Period: 2023 - 2027

Objective of the Study:

  • To analyze and forecast the market size of global bleeding disorders treatment market from 2017 to 2021.

  • To estimate and forecast the market size of global bleeding disorders treatment market from 2022 to 2027 and growth rate until 2027.

  • To classify and forecast global bleeding disorders treatment market based on drug type, disease type, distribution channel, end user, and regional distribution.

  • To identify dominant region or segment in the global bleeding disorders treatment market.

  • To identify drivers and challenges for global bleeding disorders treatment market.

  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Global bleeding disorders treatment market.

  • To identify and analyze the profile of leading players operating in Global bleeding disorders treatment market.

  • To identify key sustainable strategies adopted by market players in Global bleeding disorders treatment market.

Key Target Audience:

  • Bleeding disorders treatment vendors, end users, service providers and other stakeholders

  • Distributers and suppliers of bleeding disorders treatment's products and services and other stakeholders

  • Organizations, forums, and alliances related to bleeding disorders treatment

  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Global bleeding disorders treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Drug Type:

  • Plasma-derived Coagulation Factor Concentrates

  • Recombinant Coagulation Factor Concentrates

  • Desmopressin

  • Antifibrinolytics

  • Fibrin Sealants

  • Others

Market, By Disease Type:

  • Hemophilia A

  • Hemophilia B

  • Von Willebrand Disease

  • Others

Market, By Distribution Channel:

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online

Market, By End User:

  • Clinics

  • Hospitals

  • Research Institutes

  • Others

Market, By Region:

  • North America

  • APAC

  • Europe

  • MEA

  • South America

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Bleeding Disorders Treatment Market

4. Executive Summary

5. Voice of Customer

6. Global Bleeding Disorders Treatment Market Outlook

7. North America Bleeding Disorders Treatment Market Outlook

8. Europe Bleeding Disorders Treatment Market Outlook

9. Asia-Pacific Bleeding Disorders Treatment Market Outlook

10. Middle East and Africa Bleeding Disorders Treatment Market Outlook

11. South America Bleeding Disorders Treatment Market Outlook

12. Market Dynamics

13. Market Trends & Developments

14. Competitive Landscape

15. Strategic Recommendations

16. About the Publisher & Disclaimer

Companies Mentioned

  • Bayer AG

  • Pfizer Inc.

  • Grifols S.A.

  • Octapharma AG

  • Sun Pharmaceuticals Industries Ltd.

  • Ferring Pharmaceuticals SA

  • Amgen Inc.

  • Sanofi SA

  • Baxter International Inc.

  • F. Hoffmann-La Roche Ltd.

  • Takeda Pharmaceuticals Ltd.

  • Novo Nordisk A/S

  • Novartis AG

  • Eli Lilly and Company Ltd.

  • Gilead Sciences Inc.

For more information about this report visit https://www.researchandmarkets.com/r/3be7m5

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900